Cargando…
PD-L1 blockade potentiates the antitumor effects of ALA-PDT and optimizes the tumor microenvironment in cutaneous squamous cell carcinoma
Immune checkpoint blockade (ICB) is a powerful oncologic treatment modality for a wide variety of human malignancies, but the patient response rate to this treatment remains low, especially in patients with cutaneous squamous cell carcinoma (cSCC). 5-Aminoleuvulinic acid-photodynamic therapy (ALA-PD...
Autores principales: | Zeng, Qingyu, Yang, Jiayi, Ji, Jie, Wang, Peiru, Zhang, Linglin, Yan, Guorong, Wu, Yuhao, Chen, Qi, Liu, Jia, Zhang, Guolong, Wang, Xiuli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8986186/ https://www.ncbi.nlm.nih.gov/pubmed/35402079 http://dx.doi.org/10.1080/2162402X.2022.2061396 |
Ejemplares similares
-
Antitumor Effects of DC Vaccine With ALA-PDT-Induced Immunogenic Apoptotic
Cells for Skin Squamous Cell Carcinoma in Mice
por: Zhang, Haiyan, et al.
Publicado: (2018) -
Improvement of DC vaccine with ALA-PDT induced immunogenic apoptotic cells for skin squamous cell carcinoma
por: Ji, Jie, et al.
Publicado: (2015) -
Stimulation of dendritic cells by DAMPs in ALA-PDT treated SCC tumor cells
por: Wang, Xiaojie, et al.
Publicado: (2015) -
Single cell transcriptome profiling reveals cutaneous immune microenvironment remodeling by photodynamic therapy in photoaged skin
por: Yan, Yu, et al.
Publicado: (2023) -
NLRP3 Inflammasome Mediated Interleukin-1β Production in Cancer-Associated Fibroblast Contributes to ALA-PDT for Cutaneous Squamous Cell Carcinoma
por: Nie, Shu, et al.
Publicado: (2019)